Скачать или смотреть IRIC's virtual Symposium 2021 : GPCRs in oncology and immuno-oncology

GPCRs constitute the largest family of human membrane proteins and play a critical role in fundamental physiological and pathological processes.

With approximately one-third of marketed drugs targeting GPCRs, the ability of this family of receptors to be used as therapeutics is unmatched. However, their involvement and drug discovery potential in oncology and immuno-oncology is somewhat new.

Presided over by Michel Bouvier, CEO of IRIC, and sponsored by Domain Therapeutics, this virtual symposium showcases some of the latest discoveries and techniques leveraging the potential of GPCRs in these crucial areas.

Leading experts, such as Domain Therapeutics CTO Xavier Leroy, share the results of world-class academic and private research on GPCRs in oncology and immuno-oncology.


Speakers :
Chaired by Michel Bouvier, CEO of IRIC, Montréal
Professor Martine J. Smit, Faculty of Science, Vrije Universiteit Amsterdam
Xavier Leroy, Chief Technology Officer, Domain Therapeutics, Illkirch
Professor Silvio Gutkind, Moores Cancer Center, University of California San Diego (UCSD)